Sort
64,565 grants matching “drug discovery”
A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis
$896,814Cristiana Iosef · Advaita Corporation · R44 · FY2024 · GM
The Role of Scavenger Receptor gp340 in Mucosal HIV-1 Transmission and Inhibition
$896,761Min Lu · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · AI
HIV RNase H natural product inhibitors
$896,645Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2008 · AI
Rare Disease Translational Research
$896,627Ewy Mathã · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Algorithms for the Discovery and Geometric-Matching of Hierarchical 3-D Templates of Functional Sites in Protein Structures
$896,527Olivier Lichtarge · Baylor College Of Medicine · · FY2003 · BIO
CANCER DRUG DISCOVERY: CELL CYCLE CONTROL TARGETS
$896,446University Of South Florida · P01 · FY2001 · CA
Cancer Gene Discovery to Identify Targetable Targets
$896,280Carlo M Croce · Ohio State University · R35 · FY2019 · CA
SPORE in Bladder Cancer
$896,275Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE
$896,274Suresh S Ramalingam · Emory University · P50 · FY2024 · CA
Structure Analysis of Viral Assembly Mechanisms
$896,216Mark Jay Yeager · University Of Virginia · R01 · FY2018 · GM
Lead optimization of Novel mGlu2 Negative Allosteric Modulators
$896,201Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · MH
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
$896,077Sina Bavari · Geneva Foundation · U01 · FY2013 · AI
Inhibitors of poxvirus enzymes as novel drugs
$896,022Esteban Edward Mena · Lifepharms, Inc. · U01 · FY2009 · AI
BioGRID: An Open Integrated Resource for Biological Interaction Data
$895,794Michael David Tyers · Sinai Health System · R01 · FY2011 · RR
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$895,614Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2013 · DA
Shorter and more effective oral regimens for M. abscessus pulmonary disease
$895,538Thomas Dick · Hackensack University Medical Center · R01 · FY2025 · AI
Novel therapeutics for fatty liver disease and type-II diabetes
$895,454Sarah A Compton · Southeast Techinventures, Inc. · R44 · FY2015 · DK
Nuclear Factor-kappaB in Ovarian Cancer
$895,338Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$895,104Thomas G Bernhardt · Harvard Medical School · U19 · FY2016 · AI
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$895,058Eric L Nuermberger · Johns Hopkins University · R01 · FY2017 · AI
Development of IMPDH-Targeted Drugs against Crytosporidium
$895,013Lizbeth K. Hedstrom · Brandeis University · U01 · FY2009 · AI
Protease-resistant D-peptide Inhibitors of Ebola Virus Entry
$894,941Brett D Welch · Navigen, Inc. · R44 · FY2017 · AI
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)
$894,839Amber Dahlin · Brigham And Women'S Hospital · R01 · FY2022 · HL
Preclinical Medications Discovery and Abuse Liability Testing for NIDA
$894,744Matthew Walentiny · Virginia Commonwealth University · N01 · FY2025 · DA
Preclinical discovery of novel farnesyltransferase inhibitors for the treatment of Alzheimer's disease and related tauopathies
$894,645Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG